SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Intel steps back from Tower agreement, talks head to mediation

Defense-tech startup Tenna raises $13.5 million Seed to map the invisible battlefield

Palo Alto Networks to become Israel’s largest public company, reshaping Tel Aviv Stock Exchange

Chipmaker Tower reports record quarter as silicon photonics drives growth

Buzz

Most popular

Daily

Weekly

1

Nebius to acquire one-year-old Israeli AI startup Tavily in deal worth up to $400 million

2

Israeli defense official: “We are working on using the brain to communicate with drones”

3

“I am confident we will see a trillion-dollar Israeli company”

4

Palo Alto Networks completes CyberArk acquisition, plans Tel Aviv listing

5

Reco raises $30 million Series B to secure AI SaaS adoption across enterprises

Opthamology

4 stories about Opthamology

מוסף שבועי 30.12.21 דפנה חיים לנפורד

How one female CEO overcame adversity to find a cure for Uveitis

04.02.22|Roni Dori

"I see us building a large company that will focus on the eye, beyond Uveitis. Our technology has tremendous potential to treat other diseases that cause blindness, and treat millions of patients," says Dr. Daphne Haim-Langford, who suffers from Uveitis and founded Tarsier Pharma

דריה להמן-בלומנטל

The Israeli startup treating the silent thief of sight

30.01.22|Yafit Ovadia

BELKIN Vision is using an automated laser procedure to tackle glaucoma, a disease that can lead to irreversible blindness

אריאל ווסטין ו נועם הדס

Ophthalmic Sciences unveils world's first AI contactless device for measuring eye fluid pressure

The device combines artificial intelligence in a virtual reality-like headset, enabling tele-diagnosis and monitoring for glaucoma. The company has begun steps toward FDA approval, and is raising funds to reach additional markets

עדשות מגע זום עיניים עין

BioLight to partner with Ichilov Medical Center to develop innovative ophthalmology technologies

According to the terms of the agreement, the company will retain the primary right to license technologies developed at Ichilov